In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thermo Fisher Scientific

http://www.thermofisher.com

Latest From Thermo Fisher Scientific

News We’re Watching: Free COVID-19 Tests, Edwards Antitrust Investigation, McKinsey Calls For Medtech ‘Reinvention’

This week, the US government relaunched a program providing free COVID-19 tests and invested $600m in domestic test manufacturing; the European Commission revealed an antitrust investigation of Edwards LifeSciences; and a consulting firm report said the medtech industry should make big changes to address investor skepticism.

Commercial Regulation

Ultragenyx Faces Henrietta Lacks Suit Modeled On Action Against Thermo Fisher

While the unjust enrichment claim against Ultragenyx uses the same argument the estate of Henrietta Lacks employed against Thermo Fisher, resulting in a settlement earlier this month, one big difference between the cases is that Ultragenyx does not yet have a commercial product that relies on the HeLa cells.

Legal Issues Intellectual Property

‘The First Settlement’: Thermo Fisher Case Could Just Be Start Of The Road For Henrietta Lacks Suits

After settling for an undisclosed sum with Thermo Fisher, the estate of Henrietta Lacks signals it will initiate further lawsuits against defendants alleged to have unjustly profited from the use of HeLa cells.

Intellectual Property Legal Issues

The E in ESG: Data Reporting To Meet Healthcare’s Sustainability Challenge

High quality data reporting will be crucial if the healthcare and life sciences sectors are to achieve net zero compliance of carbon emissions. This 12th instalment of In Vivo’s rolling E in ESG series reports on the growing body of disclosure and reporting laws and platforms.

Sustainability Medical Device
See All

Company Information

  • Industry
  • Laboratory Testing Services
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • AcroMetrix Inc.
    • Affymetrix, Inc.
    • Alfa Aesar
    • Banner Pharmacaps
    • BioTrove
    • Brammer Bio
    • Core Informatics
    • DPx Holdings B.V.
    • Eureka Genomics Corporation
    • FEI Company
    • Fermentas International Inc.
    • Fisher Scientific
    • Gallu BioPharmaceuticals, LLC
    • Gatan, Inc.
    • Henogen S.A.
    • INEL Inc.
    • IRIX Pharmaceuticals
    • Life Technologies
    • Microgenics Corporation
    • Nanobac Pharmaceuticals
    • One Lambda, Inc.
    • Patheon, Inc.
    • Phadia US Inc.
    • PPD, Inc.
    • Thermo Scientific
    • Unity Lab Services
    • Zymed Inc.
UsernamePublicRestriction

Register